Biopharma Dodges Fund's Suit Alleging It Reneged On Shares
A New York federal judge has dismissed an investment fund's suit alleging a biopharmaceutical company violated a debt agreement by issuing fewer shares than owed, saying the parties' contract explicitly allows...To view the full article, register now.
Already a subscriber? Click here to view full article